PeptiDream Inc (PPTDF)
9.50
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
PeptiDream Total Liabilities (Quarterly): 206.45M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 206.45M |
| September 30, 2023 | 191.73M |
| June 30, 2023 | 184.28M |
| March 31, 2023 | 209.87M |
| December 31, 2022 | 242.72M |
| September 30, 2022 | 185.41M |
| June 30, 2022 | 198.81M |
| March 31, 2022 | 224.73M |
| December 31, 2021 | 14.64M |
| September 30, 2021 | 28.00M |
| June 30, 2021 | 19.16M |
| March 31, 2021 | 21.78M |
| December 31, 2020 | 48.96M |
| September 30, 2020 | 15.34M |
| June 30, 2020 | 19.98M |
| March 31, 2020 | 11.38M |
| September 30, 2019 | 13.13M |
| June 30, 2019 | 24.01M |
| March 31, 2019 | 10.80M |
| December 31, 2018 | 8.42M |
| September 30, 2018 | 9.438M |
| Date | Value |
|---|---|
| June 30, 2018 | 16.23M |
| March 31, 2018 | 6.530M |
| December 31, 2017 | 6.001M |
| September 30, 2017 | 8.256M |
| June 30, 2017 | 12.92M |
| March 31, 2017 | 5.297M |
| December 31, 2016 | 5.522M |
| September 30, 2016 | 7.556M |
| June 30, 2016 | 16.67M |
| March 31, 2016 | 11.05M |
| December 31, 2015 | 3.167M |
| September 30, 2015 | 1.353M |
| June 30, 2015 | 6.732M |
| March 31, 2015 | 0.9194M |
| December 31, 2014 | 0.8412M |
| September 30, 2014 | 0.8959M |
| June 30, 2014 | 1.342M |
| March 31, 2014 | 1.348M |
| December 31, 2013 | 1.542M |
| September 30, 2013 | 1.086M |
| June 30, 2013 | 2.334M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.38M
Minimum
Mar 2020
242.72M
Maximum
Dec 2022
103.35M
Average
38.48M
Median
Total Liabilities (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 53.04B |
| Nxera Pharma Co Ltd | 640.94M |
| Stemcell Holdings Inc | 6.023M |
| Healios KK | 80.04M |
| AnGes Inc | 19.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 492.57M |
| Shareholders Equity (Quarterly) | 286.12M |
| Debt to Equity Ratio | 0.5507 |
| Current Ratio | 3.159 |
| Net Debt Paydown Yield | -0.21% |